TENSOFLUX

This brand name is authorized in Germany.

Active ingredients

The drug TENSOFLUX contains a combination of these active pharmaceutical ingredients (APIs):

1	Bendroflumethiazide UNII 5Q52X6ICJI - BENDROFLUMETHIAZIDE
	Bendroflumethiazide inhibits the renal tubular absorption of salt and water by its action at the beginning of the distal convoluted tubule. Sodium and chloride ions are excreted in equivalent proportions.
	Read more about Bendroflumethiazide
2	Amiloride UNII FZJ37245UC - AMILORIDE HYDROCHLORIDE
	Amiloride has mild diuretic and anti-hypertensive activity. It acts primarily in the distal tubule and does not require aldosterone for its action. Amiloride is a mild natriuretic which does not initiate a concomitant decrease in potassium levels.
	Read more about Amiloride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03EA13	Bendroflumethiazide and potassium-sparing agents	C Cardiovascular system → C03 Diuretics → C03E Diuretics and potassium-sparing agents in combination → C03EA Low-ceiling diuretics and potassium-sparing agents
Discover more medicines within C03EA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03127942, 03127959, 03127965